Concepedia
Statistics
Publications
7
Citations
142
H-Index
Active since
2004
Affiliations
Roche (Switzerland)(Current)
Medizinische Hochschule Hannover
R Aultman is an author at Roche (Switzerland) specializing in pharmacy, healthcare cost analysis, and oncology.
Publications per year
2004–2010
Cost-Effectiveness of Erlotinib versus Docetaxel for Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer in the United Kingdom
G Lewis, Michael Peake, R Aultman et al. · Journal of International Medical Research · 2010 · 43 citations
Pharmacy, Oncology, Pharmacoeconomics +17
Effect of Influenza Treatment with Oseltamivir on Health Outcome and Costs in Otherwise Healthy Children
Keith S. Reisinger, Gerald R. Greene, R Aultman et al. · Clinical Drug Investigation · 2004 · 24 citations
Pharmacy, Child Health, Infectious Diseases +15
Patient‐reported health care utilization in rheumatoid arthritis: What level of detail is required?
Jörg Ruof, Jan L. Huelsemann, Thomas Mittendorf et al. · Arthritis Care & Research · 2004 · 19 citations
Medicine, Clinical Sciences, Internal Medicine +14
Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer
Mark Nuijten, David F. Heigener, Helge Bischoff et al. · Lung Cancer · 2010 · 17 citations
Medicine, Oncology, Pharmacology +9
A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma
R. E. Marcus, R Aultman, F Jost · British Journal of Cancer · 2009 · 16 citations · Full text
Medicine, Oncology, Pharmacotherapy +13
1–5 of 7